Languages
    • Community
      • Events
      • Iværksætterblog
      • Podcasts
      • Samarbejdspartnere
    • Lokationer
      • Symbion
      • Univate Njalsgade by Symbion
      • Univate Emil Holms Kanal by Symbion
      • Creators Floor by Symbion
      • Lydens Hus by Symbion
      • COBIS Ole Maaløes Vej by Symbion
      • COBIS Tagensvej by Symbion
    • Produkter
      • Eget kontor
      • Kontorplads
      • Membership
      • Virtuelt kontor
      • Laboratorium
      • Makerspace
      • Copenhagen Agrifood Incubator
      • Symbion Kitchen
      • Symbion Konferencecenter
    • Om Symbion
      • Historien
      • Ejerforhold
      • Medarbejdere i Symbion
    • Kontakt
    Vi forener viden og læring med iværksætteri Vi forener viden og læring med iværksætteri Vi forener viden og læring med iværksætteri
    • Community
      • Events
      • Iværksætterblog
      • Podcasts
      • Samarbejdspartnere
    • Lokationer
      • Symbion
      • Univate Njalsgade by Symbion
      • Univate Emil Holms Kanal by Symbion
      • Creators Floor by Symbion
      • Lydens Hus by Symbion
      • COBIS Ole Maaløes Vej by Symbion
      • COBIS Tagensvej by Symbion
    • Produkter
      • Eget kontor
      • Kontorplads
      • Membership
      • Virtuelt kontor
      • Laboratorium
      • Makerspace
      • Copenhagen Agrifood Incubator
      • Symbion Kitchen
      • Symbion Konferencecenter
    • Om Symbion
      • Historien
      • Ejerforhold
      • Medarbejdere i Symbion
    • Kontakt

    Developing road map for preclinical development to IND

    Hjem » Events » Developing road map for preclinical development to IND
    B2B salg for iværksættere

    Dato og tid

    24. Sep 2019, 13:30 - 16:00

    Arrangør

    COBIS & Syngene

    Sted

    COBIS, M10A+B
    Ole Maaløes Vej 3
    2200 København N

    Kategori

    Business & professional

    Pris

    Gratis

    Symposium on developing a road map for preclinical development to IND: small molecules, peptides, biologics and vaccines

     

    Please register at http://bit.ly/305zVHU to confirm your participation. Please ignore if you have already received an email confirmation on your participation.

     

    Regulatory agencies all over the world today put significant emphasis on the importance of preclinical safety evaluations. This is an important consideration for small biotechs as they may not always have toxicology experts on board.

    What should small biotechs keep in mind for toxicology studies as their compounds progress through the discovery stages of hit and lead optimization ?

    Syngene, a global CRO with over 25 years of experience of working with some of the leading pharma and biotech companies will address this question in the symposium on ‘developing a road map for preclinical development to IND’ being organized at COBIS on September 24, 2019. The event will address aspects such as a) selection of compounds through tox screening prior to development; b) what is the desired purity of the compounds;  c) what are regulatory standards for studies; d) special considerations for peptide, biologics and vaccines; e) factors that determine species selection especially selection of non-rodents for both small and large molecules; f) challenges in bioanalysis for small and large molecules; and g) adverse findings in animals studies and its relevance, translation to human and prediction of toxicity during clinical trials.

    Agenda

    1:30

    Registration and coffee

    2:00 

    Welcome and introduction

    2:05

    Role of Toxicology in supporting initiation of clinical trials and risk assessment for humans

    Srinivasa Prahalada, Ph.D, Consultant, Syngene

    2:45
    Developing a road map for successfully taking your molecule through pre- IND and IND Tox studies
    Mohan Krishnappa, Ph.D, Head – Safety Assessment, Syngene
    3:25 
    Q&A Session
    All speakers
    3:40 – 4:00
    Networking

    Speakers

    Srinivasa Prahalada, Ph.D.
    Prahalada holds a Ph.D in Comparative Pathology and MS in Anatomy from the University of California and a Bachelor’s degree in Veterinary Medicine from the University of Agricultural Sciences, Bangalore. Prior to joining Syngene in 2016, he was working with Merck and Company (MSD) for over 28 years during which period he moved up the ranks to become the Head of Pathology in Safety Assessment. He was responsible for preclinical development of many compounds which resulted in successful registration globally. 
    He was also the Head of Pathology at the Regional Primate Center, University of California, Davis for 3 years. Dr Prahalada has an impressive list of scientific publications in peer-reviewed journals in the areas of developmental pathology, anatomic pathology, toxicology and reproductive endocrinology.
    Mohan Krishnappa, Ph.D.

    Krishnappa is a lead toxicologist with over 8 years of GLP experience in safety evaluation of chemicals and drugs to support drug discovery and development. He has worked as scientific coordinator/monitoring scientist for IND enabling toxicology and safety pharmacology programs specifically for EU clients. 
    He has a degree in veterinary medicine and masters and doctorate in the field of veterinary pharmacology and toxicology from Veterinary college, Bangalore, India.

    Dato og tid

    24. Sep 2019, 13:30 - 16:00

    Arrangør

    COBIS & Syngene

    Sted

    COBIS, M10A+B
    Ole Maaløes Vej 3
    2200 København N

    Kategori

    Business & professional

    Pris

    Gratis
    Symbion A/S

    Fruebjergvej 3
    2100 København Ø

    +45 3917 9999
    info@symbion.dk

    CVR: 10369703

    Om Symbion
    • Kontorfællesskab i København
    • Om Symbion
    • Ejerforhold
    • Medarbejdere i Symbion
    • Job
    • Persondatapolitik
    • Cookiepolitik
    Information
    • Prisberegner
    • Virksomheder i Symbion
    • Iværksætternetværk
    • Kontorfællesskab eller kontorhotel?
    • Nyhedsbrev
    • Pressemateriale
    • Parkeringsinformation
    Vores afdelinger
    • Symbion
    • Creators Floor by Symbion
    • Univate Njalsgade by Symbion
    • Univate Emil Holms Kanal by Symbion
    • COBIS by Symbion
    • Lydens Hus by Symbion
    • Symbion Konferencecenter København
    For lejere
    • Mit Symbion Intranet
    • Book mødelokaler
    • Book konferencelokaler
    • Facebook Gruppe
    Følg os på
    DanBAN Open Office Hours – Brug for knowhow eller investorer?
    Værdien af advisory boards og professionelle bestyrelser